Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Depreciation & Amortization (IS): 2011-2021

Historic Depreciation & Amortization (IS) for Abeona Therapeutics (ABEO) over the last 10 years, with Dec 2021 value amounting to $807,000.

  • Abeona Therapeutics' Depreciation & Amortization (IS) fell 3.93% to $807,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $3.2 million, marking a year-over-year decrease of 29.13%. This contributed to the annual value of $3.2 million for FY2021, which is 29.13% down from last year.
  • Abeona Therapeutics' Depreciation & Amortization (IS) amounted to $807,000 in Q4 2021, which was up 0.62% from $802,000 recorded in Q3 2021.
  • Abeona Therapeutics' 5-year Depreciation & Amortization (IS) high stood at $2.1 million for Q1 2020, and its period low was $138,000 during Q3 2017.
  • Over the past 3 years, Abeona Therapeutics' median Depreciation & Amortization (IS) value was $837,000 (recorded in 2020), while the average stood at $1.2 million.
  • Per our database at Business Quant, Abeona Therapeutics' Depreciation & Amortization (IS) surged by 852.87% in 2019 and then plummeted by 60.44% in 2021.
  • Quarterly analysis of 5 years shows Abeona Therapeutics' Depreciation & Amortization (IS) stood at $146,000 in 2017, then skyrocketed by 852.74% to $1.4 million in 2018, then surged by 609.31% to $2.1 million in 2019, then tumbled by 59.46% to $840,000 in 2020, then fell by 3.93% to $807,000 in 2021.
  • Its Depreciation & Amortization (IS) was $807,000 in Q4 2021, compared to $802,000 in Q3 2021 and $824,000 in Q2 2021.